Table 2.
Effects of notoginsenoside R1 and ginsenoside Rg1 on body weight in ICR mice.
| Group | Treatment (mg/kg) | Body weight (g)a | ||
|---|---|---|---|---|
|
| ||||
| Initial | Intermediate | Final | ||
| Controlb | - | 27.41 ± 1.30 | 31.00 ± 2.09 | 35.42 ± 2.81 |
| R1-low dosage | 5 | 27.63 ± 1.28 | 30.41 ± 3.91 | 33.82 ± 3.50 |
| R1-high dosage | 20 | 27.78 ± 0.70 | 31.60 ± 0.74 | 34.92 ± 0.69 |
| Rg1-low dosage | 5 | 27.41 ± 1.02 | 30.67 ± 2.27 | 33.88 ± 2.35 |
| Rg1-high dosage | 20 | 28.27 ± 0.92 | 32.23 ± 2.11 | 35.11 ± 1.60 |
aData are expressed as mean ± S.E.;
bphosphate buffer saline was given to mice as a negative control; 12 ICR strain mice were observed and tested for each group during the experimental period.